Johnson & Johnson suspends sales forecast for Covid vaccine
Johnson & Johnson suspended sales forecasts for its Covid-19 vaccine during the American pharmaceutical giant’s quarterly earnings call Tuesday, as demand lags behind that of shots by Moderna and Pfizer. “Given global supply surplus and demand uncertainty, the Company is suspending COVID-19 Vaccine sales guidance,” J&J said in a statement,